Nov 09, 2022 / 04:35PM GMT
Daniel Louis Leonard - Crédit Suisse AG - Research Division - Research Analyst
All right. Greenlight means [re-life]. Our next session is Bio-Techne. We're lucky to have with us CEO of Bio-Techne, Chuck Kummeth. I'm Dan Leonard, I'm the life science tools analyst at Credit Suisse. Welcome, Chuck.
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Glad to be here, Dan.
Questions and Answers:
Daniel Louis Leonard - Crédit Suisse AG - Research Division - Research AnalystThanks for coming. You just reported your quarter a week ago. So I thought a good way to start-off the fireside chat would be to highlight key takeaways from your September quarter results.
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Sure. Well, the first thing is here it was, missed top line, I wouldn't say bottom line, but first missed ten or 11 quarters or so. But we kind of talked about that